KPS Corporation

256940 · KQ · Consumer Defensive / Household & Personal Products

4,885.00KRW+85.00 (+1.77%)

Price History

Full chart

Market Stats

Previous Close4,800.00

Open4,805.00

Day Range4,805.00 – 5,030.00

52-Week Range5,110.00 – 12,880.00

Volume19.17K

Market Cap139.54B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta1.03

50-Day Avg5,868.60

200-Day Avg7,510.55

About

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Company Details

SectorConsumer Defensive
IndustryHousehold & Personal Products
CEOYoung Kim Ha
Employees107
Headquarters52, Dongtansandan 10-gil, Hwaseong-si, South Korea, 18487, Korea
Websitehttps://www.kpscorp.co.kr/kps/index.php

Leadership

Young Kim HaChief Executive Officer
Jung Ho KimCEO of KPS Technology Division

Financials

Income Statement

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	8.56B	17.55B	24.04B	40.63B	14.19B	15.22B	4.26B	14.62B	92.13B	127.58B	170.15B
Growth (%)	-	+105.09%	+37.02%	+68.98%	-65.07%	+7.23%	-72.00%	+243.08%	+530.30%	+38.48%	+33.36%
Cost of Revenue	7.41B	11.44B	14.80B	26.64B	10.61B	11.27B	5.05B	13.57B	79.34B	110.34B	132.57B
Gross Profit	1.15B	6.11B	9.24B	13.99B	3.58B	3.95B	-788.97M	1.04B	12.80B	17.24B	37.58B
Gross Margin	13.42%	34.79%	38.44%	34.44%	25.23%	25.94%	-18.52%	7.14%	13.89%	13.51%	22.08%
Operating Expense	2.07B	3.38B	4.98B	6.38B	4.55B	4.33B	11.52B	8.81B	1.62B	11.02B	36.00B
Operating Income	-925.32M	2.72B	4.26B	7.61B	-973.01M	-387.13M	-12.31B	-7.76B	11.18B	6.22B	1.57B
Operating Margin	-10.81%	15.52%	17.74%	18.74%	-6.86%	-2.54%	-288.86%	-53.10%	12.13%	4.87%	0.93%
EBITDA	-	-	-	-	-	-	-	-11.95B	8.84B	9.68B	-49.66M
EBITDA Margin	-	-	-	-	-	-	-	-81.75%	9.60%	7.59%	-0.03%
Net Income	-1.43B	2.56B	2.19B	6.81B	-346.43M	-2.41B	-15.32B	-11.38B	3.93B	1.11B	-9.79B
Net Income Margin	-16.77%	14.56%	9.12%	16.75%	-2.44%	-15.81%	-359.52%	-77.82%	4.27%	0.87%	-5.75%
R&D	-	-	354.78M	604.41M	-	829.90M	2.81B	2.16B	1.45B	801.38M	2.59B
R&D as % of Total Revenue	-	-	1.48%	1.49%	-	5.45%	65.95%	14.81%	1.57%	0.63%	1.52%
Interest Expense	0	0	0	0	0	1.67B	1.69B	934.70M	2.03B	3.73B	7.17B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	10.94%	39.67%	6.39%	2.20%	2.92%	4.21%

Balance Sheet

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	13.66B	27.05B	32.50B	38.23B	38.65B	76.99B	93.40B	85.56B	117.28B	165.21B	233.92B
Total Liabilities	18.53B	20.80B	6.75B	7.32B	8.35B	26.83B	32.38B	32.49B	58.70B	101.99B	152.41B
Total Equity	-4.86B	6.25B	25.75B	30.91B	30.30B	50.16B	61.03B	53.07B	57.24B	50.13B	62.01B
Cash	-	2.53B	829.50M	11.17M	4.40B	31.15B	37.20B	23.62B	4.11B	18.78B	22.04B
Total Debt	7.94B	10.03B	1.53B	460.00M	74.59M	4.68B	-	-	-	-	-
Net Debt	-	-	-	-	1.06B	-	-	4.50B	43.80B	36.62B	70.06B

Cash Flow

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	1.58B	6.48B	2.37B	-731.24M	-1.74B	-8.38B	-866.26M	-57.13M	4.81B	-14.92B
Investing Cash Flow	-	-977.20M	-12.72B	-2.62B	893.48M	-9.53B	-14.28B	-9.43B	-27.59B	-22.27B	-
Financing Cash Flow	-	1.88B	4.54B	-565.78M	4.10B	38.69B	28.03B	-3.27B	8.15B	31.93B	-
Capital Expenditure	0	1.13B	618.26M	5.30B	23.93M	1.04B	90.75M	95.85M	1.07B	6.70B	34.89B
Free Cash Flow	-	-	-	-	-	-3.43B	-8.50B	-996.08M	-1.13B	-1.89B	-49.81B
Dividends Paid	-	-	427.90M	427.90M	427.90M	-	-	-	-	-	-
FCF to OCF	-	-	-	-	-	197.42%	101.47%	114.99%	1974.30%	-39.34%	333.81%

Earnings

Report Date	May 30, 2017	Aug 16, 2017	Sep 30, 2017	Feb 14, 2018	May 15, 2018	Aug 14, 2018	Nov 12, 2018	Feb 12, 2019	May 15, 2019	Aug 14, 2019	Nov 14, 2019	Feb 14, 2020	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	194.78	81.76	13.91	-38.77	-7.99	52.26	254.01	231.67	94.00	-21.87	5.48	-104.52	78.44	-59.25	-160.16	-5.12	-105.27	-169.63	-93.19	-488.38	-103.14	-70.34	-2.81	-430.65	-95.43	-42.16	-11.97	359.19	355.52	-258.73	-88.74	51.34	-92.00	59.56	-22.46	-438.00	282.26	-436.50
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	After-hours	-	Pre-market	Pre-market	Pre-market	After-hours	-	Pre-market	Pre-market	Pre-market	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap139.54B

Enterprise Value188.15B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.63

Price / Book1.95

Revenue (TTM)220.48B

Gross Profit (TTM)39.55B

EBITDA4.84B

Profit Margin-5.62%

Operating Margin-3.20%

Return on Equity-15.58%

Return on Assets-0.17%

Shares Outstanding20.08M

Shares Float14.74M

Beta1.03

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20191×

100.00Dec 27, 2019

20181×

33.33Dec 27, 2018

Stock Splits

May 20, 2020959692:319897